Study of octreotide delivered via solid dose injector

Trial Profile

Study of octreotide delivered via solid dose injector

Phase of Trial: Phase I

Latest Information Update: 28 Jun 2016

At a glance

  • Drugs Octreotide (Primary)
  • Indications Acromegaly
  • Focus Pharmacokinetics; Proof of concept
  • Sponsors Glide Technologies
  • Most Recent Events

    • 28 Jun 2016 Results published in a Glide Technologies media release.
    • 28 Jun 2016 According to a Glide Technologies media release, status changed from recruiting to completed.
    • 19 May 2016 Status changed from planning to recruiting, according to Glide Technologies media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top